Last Funding Type: Series C
Headquarters: Herzliya, Tel Aviv, Israel
Founded Date: 2015-01-01
Investor Type: Late Stage Venture
Last Funding Date: 2020
Total Funding: 43000000
Technology: Intracellular communication
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 7
Industry: Longevity Medicine